(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Monday the launch of Fenofibrate Tablets USP, a therapeutic equivalent generic version of Tricor (fenofibrate) Tablets, in the U.S. market.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes and high levels of uric acid ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that ...
A new analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial has shown that the lipid-lowering therapy works just as well in women as in men. These results are key, say ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. FENOFIBRATE VIATRIS contains the active ingredient fenofibrate.
Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy (DR), conclude authors of an Article published early Online and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback